Found 64 hits with Last Name = 'muttenthaler' and Initial = 'm' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332720
((S)-1-((4R,7S,10S,13S,16S,19R)-4-amino-16-(2-amino...)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)NCC(N)=O |r| Show InChI InChI=1S/C42H66N12O11SSe/c1-5-22(4)35-41(64)48-26(12-13-31(44)56)37(60)50-28(17-32(45)57)38(61)51-29(42(65)54-14-6-7-30(54)40(63)52-34(15-21(2)3)47-18-33(46)58)19-66-67-20-25(43)36(59)49-27(39(62)53-35)16-23-8-10-24(55)11-9-23/h8-11,21-22,25-30,34-35,47,55H,5-7,12-20,43H2,1-4H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,48,64)(H,49,59)(H,50,60)(H,51,61)(H,52,63)(H,53,62)/t22-,25-,26-,27-,28-,29-,30-,34-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.290 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332721
((S)-N-((S)-1-(2-amino-2-oxoethylamino)-3-methylbut...)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)NCC(N)=O |r| Show InChI InChI=1S/C42H66N12O11SSe/c1-5-22(4)35-41(64)48-26(12-13-31(44)56)37(60)50-28(17-32(45)57)38(61)51-29(42(65)54-14-6-7-30(54)40(63)52-34(15-21(2)3)47-18-33(46)58)20-67-66-19-25(43)36(59)49-27(39(62)53-35)16-23-8-10-24(55)11-9-23/h8-11,21-22,25-30,34-35,47,55H,5-7,12-20,43H2,1-4H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,48,64)(H,49,59)(H,50,60)(H,51,61)(H,52,63)(H,53,62)/t22-,25-,26-,27-,28-,29-,30-,34-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.720 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50205990
(CHEMBL395429 | OXYTOCIN)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 0.790 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332723
(CHEMBL1630531 | Cystathionine Oxytocin)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(N)CCSCC(NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C44H67N11O13S/c1-5-23(4)36-43(67)49-27(12-13-33(46)57)39(63)51-30(19-34(47)58)40(64)53-31(21-69-16-14-26(45)37(61)50-29(41(65)54-36)18-24-8-10-25(56)11-9-24)44(68)55-15-6-7-32(55)42(66)52-28(17-22(2)3)38(62)48-20-35(59)60/h8-11,22-23,26-32,36,56H,5-7,12-21,45H2,1-4H3,(H2,46,57)(H2,47,58)(H,48,62)(H,49,67)(H,50,61)(H,51,63)(H,52,66)(H,53,64)(H,54,65)(H,59,60)/t23-,26?,27-,28-,29-,30-,31?,32-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332724
((S)-N-((S)-1-(2-amino-2-oxoethylamino)-3-methylbut...)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Te][Te]C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)NCC(N)=O |r| Show InChI InChI=1S/C42H66N12O11Te2/c1-5-22(4)35-41(64)48-26(12-13-31(44)56)37(60)50-28(17-32(45)57)38(61)51-29(42(65)54-14-6-7-30(54)40(63)52-34(15-21(2)3)47-18-33(46)58)20-67-66-19-25(43)36(59)49-27(39(62)53-35)16-23-8-10-24(55)11-9-23/h8-11,21-22,25-30,34-35,47,55H,5-7,12-20,43H2,1-4H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,48,64)(H,49,59)(H,50,60)(H,51,61)(H,52,63)(H,53,62)/t22-,25-,26-,27-,28-,29-,30-,34-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 7.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332725
((S)-N-((S)-1-(2-amino-2-oxoethylamino)-3-methylbut...)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)NCC(N)=O |r| Show InChI InChI=1S/C42H66N12O11Se2/c1-5-22(4)35-41(64)48-26(12-13-31(44)56)37(60)50-28(17-32(45)57)38(61)51-29(42(65)54-14-6-7-30(54)40(63)52-34(15-21(2)3)47-18-33(46)58)20-67-66-19-25(43)36(59)49-27(39(62)53-35)16-23-8-10-24(55)11-9-23/h8-11,21-22,25-30,34-35,47,55H,5-7,12-20,43H2,1-4H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,48,64)(H,49,59)(H,50,60)(H,51,61)(H,52,63)(H,53,62)/t22-,25-,26-,27-,28-,29-,30-,34-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 11.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50291330
(1-[19-Amino-13-benzyl-10-(2-carbamoyl-ethyl)-7-car...)Show SMILES N[C@@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O Show InChI InChI=1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28+,29-,30-,31+,32+,33+,34-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332726
(CHEMBL1630530 | Lanthionine Oxytocin)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(N)CSCC(NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C43H65N11O13S/c1-5-22(4)35-42(66)48-26(12-13-32(45)56)38(62)50-29(17-33(46)57)39(63)52-30(20-68-19-25(44)36(60)49-28(40(64)53-35)16-23-8-10-24(55)11-9-23)43(67)54-14-6-7-31(54)41(65)51-27(15-21(2)3)37(61)47-18-34(58)59/h8-11,21-22,25-31,35,55H,5-7,12-20,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,61)(H,48,66)(H,49,60)(H,50,62)(H,51,65)(H,52,63)(H,53,64)(H,58,59)/t22-,25?,26-,27-,28-,29-,30?,31-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 856 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332727
(CHEMBL1630532 | cyclo(CYIQNCPLG))Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC1=O)C(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2 |r| Show InChI InChI=1S/C42H61N11O12S2/c1-5-21(4)32-40(63)47-24(12-13-30(43)55)36(59)52-33(34(44)57)41(64)50-28-19-67-66-18-27(38(61)48-26(37(60)51-32)16-22-8-10-23(54)11-9-22)46-31(56)17-45-35(58)25(15-20(2)3)49-39(62)29-7-6-14-53(29)42(28)65/h8-11,20-21,24-29,32-33,54H,5-7,12-19H2,1-4H3,(H2,43,55)(H2,44,57)(H,45,58)(H,46,56)(H,47,63)(H,48,61)(H,49,62)(H,50,64)(H,51,60)(H,52,59)/t21-,24-,25-,26-,27-,28-,29-,32-,33-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332726
(CHEMBL1630530 | Lanthionine Oxytocin)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(N)CSCC(NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O |r| Show InChI InChI=1S/C43H65N11O13S/c1-5-22(4)35-42(66)48-26(12-13-32(45)56)38(62)50-29(17-33(46)57)39(63)52-30(20-68-19-25(44)36(60)49-28(40(64)53-35)16-23-8-10-24(55)11-9-23)43(67)54-14-6-7-31(54)41(65)51-27(15-21(2)3)37(61)47-18-34(58)59/h8-11,21-22,25-31,35,55H,5-7,12-20,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,61)(H,48,66)(H,49,60)(H,50,62)(H,51,65)(H,52,63)(H,53,64)(H,58,59)/t22-,25?,26-,27-,28-,29-,30?,31-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332728
(CHEMBL1630533 | cyclo(CYIQNCPLGAGAGAG)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CSSC[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N2 |r| Show InChI InChI=1S/C58H87N17O18S2/c1-8-28(4)47-57(92)69-34(15-16-41(59)77)52(87)71-37(20-42(60)78)53(88)73-39-26-95-94-25-38(55(90)70-36(54(89)74-47)19-32-11-13-33(76)14-12-32)68-46(82)24-63-50(85)31(7)66-44(80)22-61-48(83)29(5)65-43(79)21-62-49(84)30(6)67-45(81)23-64-51(86)35(18-27(2)3)72-56(91)40-10-9-17-75(40)58(39)93/h11-14,27-31,34-40,47,76H,8-10,15-26H2,1-7H3,(H2,59,77)(H2,60,78)(H,61,83)(H,62,84)(H,63,85)(H,64,86)(H,65,79)(H,66,80)(H,67,81)(H,68,82)(H,69,92)(H,70,90)(H,71,87)(H,72,91)(H,73,88)(H,74,89)/t28-,29+,30-,31-,34-,35-,36-,37-,38-,39+,40-,47-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332729
((4S,7R,10S,13R,16R,19S)-16-(2-amino-2-oxoethyl)-13...)Show SMILES CC[C@@H](C)[C@@H]1NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CSSC[C@@H](NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O)C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)CN |r| Show InChI InChI=1S/C43H65N11O13S2/c1-5-22(4)35-41(64)50-26(16-23-8-10-24(55)11-9-23)37(60)52-30(43(66)67)20-69-68-19-29(39(62)49-27(17-33(46)57)38(61)48-25(36(59)53-35)12-13-32(45)56)51-40(63)31-7-6-14-54(31)42(65)28(15-21(2)3)47-34(58)18-44/h8-11,21-22,25-31,35,55H,5-7,12-20,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,58)(H,48,61)(H,49,62)(H,50,64)(H,51,63)(H,52,60)(H,53,59)(H,66,67)/t22-,25-,26-,27-,28-,29-,30-,31-,35+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50332730
((R)-N-((R)-1-(2-amino-2-oxoethylamino)-3-methylbut...)Show SMILES CC[C@@H](C)[C@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CC(C)C)NCC(N)=O |r| Show InChI InChI=1S/C42H66N12O11S2/c1-5-22(4)35-41(64)48-26(12-13-31(44)56)37(60)50-28(17-32(45)57)38(61)51-29(42(65)54-14-6-7-30(54)40(63)52-34(15-21(2)3)47-18-33(46)58)20-67-66-19-25(43)36(59)49-27(39(62)53-35)16-23-8-10-24(55)11-9-23/h8-11,21-22,25-30,34-35,47,55H,5-7,12-20,43H2,1-4H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,48,64)(H,49,59)(H,50,60)(H,51,61)(H,52,63)(H,53,62)/t22-,25-,26-,27-,28-,29-,30-,34-,35-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
The University of Queensland
Curated by ChEMBL
| Assay Description Displacement of [3H]OT from oxytocin receptor expressed in COS1 cells |
J Med Chem 53: 8585-96 (2010)
Article DOI: 10.1021/jm100989w BindingDB Entry DOI: 10.7270/Q2CC10X9 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536276
(CHEMBL4564152)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-3-23(2)36-42(66)51-27(13-14-32(45)57)38(62)52-29(20-33(46)58)39(63)53-30(22-69-68-18-15-35(60)49-28(40(64)54-36)19-24-9-11-25(56)12-10-24)43(67)55-17-6-8-31(55)41(65)50-26(7-4-5-16-44)37(61)48-21-34(47)59/h9-12,23,26-31,36,56H,3-8,13-22,44H2,1-2H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,65)(H,51,66)(H,52,62)(H,53,63)(H,54,64)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.265 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Gga... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536277
(CHEMBL4541104)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C96H146N24O26S4/c1-5-53(3)81-93(143)111-61(33-35-71(97)123)85(135)113-65(47-73(99)125)87(137)115-67(51-149-147-43-37-79(131)107-63(89(139)117-81)45-55-25-29-57(121)30-26-55)95(145)119-41-17-21-69(119)91(141)109-59(83(133)105-49-75(101)127)19-13-15-39-103-77(129)23-11-9-7-8-10-12-24-78(130)104-40-16-14-20-60(84(134)106-50-76(102)128)110-92(142)70-22-18-42-120(70)96(146)68-52-150-148-44-38-80(132)108-64(46-56-27-31-58(122)32-28-56)90(140)118-82(54(4)6-2)94(144)112-62(34-36-72(98)124)86(136)114-66(48-74(100)126)88(138)116-68/h25-32,53-54,59-70,81-82,121-122H,5-24,33-52H2,1-4H3,(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H,103,129)(H,104,130)(H,105,133)(H,106,134)(H,107,131)(H,108,132)(H,109,141)(H,110,142)(H,111,143)(H,112,144)(H,113,135)(H,114,136)(H,115,137)(H,116,138)(H,117,139)(H,118,140)/t53-,54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,81-,82-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 an... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536275
(CHEMBL4520203)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C98H150N24O26S4/c1-5-55(3)83-95(145)113-63(35-37-73(99)125)87(137)115-67(49-75(101)127)89(139)117-69(53-151-149-45-39-81(133)109-65(91(141)119-83)47-57-27-31-59(123)32-28-57)97(147)121-43-19-23-71(121)93(143)111-61(85(135)107-51-77(103)129)21-15-17-41-105-79(131)25-13-11-9-7-8-10-12-14-26-80(132)106-42-18-16-22-62(86(136)108-52-78(104)130)112-94(144)72-24-20-44-122(72)98(148)70-54-152-150-46-40-82(134)110-66(48-58-29-33-60(124)34-30-58)92(142)120-84(56(4)6-2)96(146)114-64(36-38-74(100)126)88(138)116-68(50-76(102)128)90(140)118-70/h27-34,55-56,61-72,83-84,123-124H,5-26,35-54H2,1-4H3,(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H,105,131)(H,106,132)(H,107,135)(H,108,136)(H,109,133)(H,110,134)(H,111,143)(H,112,144)(H,113,145)(H,114,146)(H,115,137)(H,116,138)(H,117,139)(H,118,140)(H,119,141)(H,120,142)/t55-,56-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,83-,84-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 182 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagge... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536277
(CHEMBL4541104)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C96H146N24O26S4/c1-5-53(3)81-93(143)111-61(33-35-71(97)123)85(135)113-65(47-73(99)125)87(137)115-67(51-149-147-43-37-79(131)107-63(89(139)117-81)45-55-25-29-57(121)30-26-55)95(145)119-41-17-21-69(119)91(141)109-59(83(133)105-49-75(101)127)19-13-15-39-103-77(129)23-11-9-7-8-10-12-24-78(130)104-40-16-14-20-60(84(134)106-50-76(102)128)110-92(142)70-22-18-42-120(70)96(146)68-52-150-148-44-38-80(132)108-64(46-56-27-31-58(122)32-28-56)90(140)118-82(54(4)6-2)94(144)112-62(34-36-72(98)124)86(136)114-66(48-74(100)126)88(138)116-68/h25-32,53-54,59-70,81-82,121-122H,5-24,33-52H2,1-4H3,(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H,103,129)(H,104,130)(H,105,133)(H,106,134)(H,107,131)(H,108,132)(H,109,141)(H,110,142)(H,111,143)(H,112,144)(H,113,135)(H,114,136)(H,115,137)(H,116,138)(H,117,139)(H,118,140)/t53-,54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,81-,82-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.00300 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Gga... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536277
(CHEMBL4541104)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C96H146N24O26S4/c1-5-53(3)81-93(143)111-61(33-35-71(97)123)85(135)113-65(47-73(99)125)87(137)115-67(51-149-147-43-37-79(131)107-63(89(139)117-81)45-55-25-29-57(121)30-26-55)95(145)119-41-17-21-69(119)91(141)109-59(83(133)105-49-75(101)127)19-13-15-39-103-77(129)23-11-9-7-8-10-12-24-78(130)104-40-16-14-20-60(84(134)106-50-76(102)128)110-92(142)70-22-18-42-120(70)96(146)68-52-150-148-44-38-80(132)108-64(46-56-27-31-58(122)32-28-56)90(140)118-82(54(4)6-2)94(144)112-62(34-36-72(98)124)86(136)114-66(48-74(100)126)88(138)116-68/h25-32,53-54,59-70,81-82,121-122H,5-24,33-52H2,1-4H3,(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H,103,129)(H,104,130)(H,105,133)(H,106,134)(H,107,131)(H,108,132)(H,109,141)(H,110,142)(H,111,143)(H,112,144)(H,113,135)(H,114,136)(H,115,137)(H,116,138)(H,117,139)(H,118,140)/t53-,54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,81-,82-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggam... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536275
(CHEMBL4520203)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C98H150N24O26S4/c1-5-55(3)83-95(145)113-63(35-37-73(99)125)87(137)115-67(49-75(101)127)89(139)117-69(53-151-149-45-39-81(133)109-65(91(141)119-83)47-57-27-31-59(123)32-28-57)97(147)121-43-19-23-71(121)93(143)111-61(85(135)107-51-77(103)129)21-15-17-41-105-79(131)25-13-11-9-7-8-10-12-14-26-80(132)106-42-18-16-22-62(86(136)108-52-78(104)130)112-94(144)72-24-20-44-122(72)98(148)70-54-152-150-46-40-82(134)110-66(48-58-29-33-60(124)34-30-58)92(142)120-84(56(4)6-2)96(146)114-64(36-38-74(100)126)88(138)116-68(50-76(102)128)90(140)118-70/h27-34,55-56,61-72,83-84,123-124H,5-26,35-54H2,1-4H3,(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H,105,131)(H,106,132)(H,107,135)(H,108,136)(H,109,133)(H,110,134)(H,111,143)(H,112,144)(H,113,145)(H,114,146)(H,115,137)(H,116,138)(H,117,139)(H,118,140)(H,119,141)(H,120,142)/t55-,56-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,83-,84-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 38 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536278
(CHEMBL4520170)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C94H142N24O26S4/c1-5-51(3)79-91(141)109-59(31-33-69(95)121)83(133)111-63(45-71(97)123)85(135)113-65(49-147-145-41-35-77(129)105-61(87(137)115-79)43-53-23-27-55(119)28-24-53)93(143)117-39-15-19-67(117)89(139)107-57(81(131)103-47-73(99)125)17-11-13-37-101-75(127)21-9-7-8-10-22-76(128)102-38-14-12-18-58(82(132)104-48-74(100)126)108-90(140)68-20-16-40-118(68)94(144)66-50-148-146-42-36-78(130)106-62(44-54-25-29-56(120)30-26-54)88(138)116-80(52(4)6-2)92(142)110-60(32-34-70(96)122)84(134)112-64(46-72(98)124)86(136)114-66/h23-30,51-52,57-68,79-80,119-120H,5-22,31-50H2,1-4H3,(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H,101,127)(H,102,128)(H,103,131)(H,104,132)(H,105,129)(H,106,130)(H,107,139)(H,108,140)(H,109,141)(H,110,142)(H,111,133)(H,112,134)(H,113,135)(H,114,136)(H,115,137)(H,116,138)/t51-,52-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,79-,80-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 67 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggam... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536276
(CHEMBL4564152)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-3-23(2)36-42(66)51-27(13-14-32(45)57)38(62)52-29(20-33(46)58)39(63)53-30(22-69-68-18-15-35(60)49-28(40(64)54-36)19-24-9-11-25(56)12-10-24)43(67)55-17-6-8-31(55)41(65)50-26(7-4-5-16-44)37(61)48-21-34(47)59/h9-12,23,26-31,36,56H,3-8,13-22,44H2,1-2H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,65)(H,51,66)(H,52,62)(H,53,63)(H,54,64)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 75 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggam... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536279
(CHEMBL4567752)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C100H154N24O26S4/c1-5-57(3)85-97(147)115-65(37-39-75(101)127)89(139)117-69(51-77(103)129)91(141)119-71(55-153-151-47-41-83(135)111-67(93(143)121-85)49-59-29-33-61(125)34-30-59)99(149)123-45-21-25-73(123)95(145)113-63(87(137)109-53-79(105)131)23-17-19-43-107-81(133)27-15-13-11-9-7-8-10-12-14-16-28-82(134)108-44-20-18-24-64(88(138)110-54-80(106)132)114-96(146)74-26-22-46-124(74)100(150)72-56-154-152-48-42-84(136)112-68(50-60-31-35-62(126)36-32-60)94(144)122-86(58(4)6-2)98(148)116-66(38-40-76(102)128)90(140)118-70(52-78(104)130)92(142)120-72/h29-36,57-58,63-74,85-86,125-126H,5-28,37-56H2,1-4H3,(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H2,105,131)(H2,106,132)(H,107,133)(H,108,134)(H,109,137)(H,110,138)(H,111,135)(H,112,136)(H,113,145)(H,114,146)(H,115,147)(H,116,148)(H,117,139)(H,118,140)(H,119,141)(H,120,142)(H,121,143)(H,122,144)/t57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,85-,86-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536280
(CHEMBL4546103)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C92H138N24O26S4/c1-5-49(3)77-89(139)107-57(29-31-67(93)119)81(131)109-61(43-69(95)121)83(133)111-63(47-145-143-39-33-75(127)103-59(85(135)113-77)41-51-21-25-53(117)26-22-51)91(141)115-37-13-17-65(115)87(137)105-55(79(129)101-45-71(97)123)15-9-11-35-99-73(125)19-7-8-20-74(126)100-36-12-10-16-56(80(130)102-46-72(98)124)106-88(138)66-18-14-38-116(66)92(142)64-48-146-144-40-34-76(128)104-60(42-52-23-27-54(118)28-24-52)86(136)114-78(50(4)6-2)90(140)108-58(30-32-68(94)120)82(132)110-62(44-70(96)122)84(134)112-64/h21-28,49-50,55-66,77-78,117-118H,5-20,29-48H2,1-4H3,(H2,93,119)(H2,94,120)(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H,99,125)(H,100,126)(H,101,129)(H,102,130)(H,103,127)(H,104,128)(H,105,137)(H,106,138)(H,107,139)(H,108,140)(H,109,131)(H,110,132)(H,111,133)(H,112,134)(H,113,135)(H,114,136)/t49-,50-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,77-,78-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536281
(CHEMBL4532537)Show SMILES CCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C51H80N12O13S2/c1-4-6-7-8-9-15-42(68)55-23-11-10-13-33(45(70)56-28-41(54)67)58-49(74)38-14-12-24-63(38)51(76)37-29-78-77-25-22-43(69)57-35(26-31-16-18-32(64)19-17-31)48(73)62-44(30(3)5-2)50(75)59-34(20-21-39(52)65)46(71)60-36(27-40(53)66)47(72)61-37/h16-19,30,33-38,44,64H,4-15,20-29H2,1-3H3,(H2,52,65)(H2,53,66)(H2,54,67)(H,55,68)(H,56,70)(H,57,69)(H,58,74)(H,59,75)(H,60,71)(H,61,72)(H,62,73)/t30-,33-,34-,35-,36-,37-,38-,44-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| KEGG PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 4.10 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536276
(CHEMBL4564152)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-3-23(2)36-42(66)51-27(13-14-32(45)57)38(62)52-29(20-33(46)58)39(63)53-30(22-69-68-18-15-35(60)49-28(40(64)54-36)19-24-9-11-25(56)12-10-24)43(67)55-17-6-8-31(55)41(65)50-26(7-4-5-16-44)37(61)48-21-34(47)59/h9-12,23,26-31,36,56H,3-8,13-22,44H2,1-2H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,65)(H,51,66)(H,52,62)(H,53,63)(H,54,64)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536280
(CHEMBL4546103)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C92H138N24O26S4/c1-5-49(3)77-89(139)107-57(29-31-67(93)119)81(131)109-61(43-69(95)121)83(133)111-63(47-145-143-39-33-75(127)103-59(85(135)113-77)41-51-21-25-53(117)26-22-51)91(141)115-37-13-17-65(115)87(137)105-55(79(129)101-45-71(97)123)15-9-11-35-99-73(125)19-7-8-20-74(126)100-36-12-10-16-56(80(130)102-46-72(98)124)106-88(138)66-18-14-38-116(66)92(142)64-48-146-144-40-34-76(128)104-60(42-52-23-27-54(118)28-24-52)86(136)114-78(50(4)6-2)90(140)108-58(30-32-68(94)120)82(132)110-62(44-70(96)122)84(134)112-64/h21-28,49-50,55-66,77-78,117-118H,5-20,29-48H2,1-4H3,(H2,93,119)(H2,94,120)(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H,99,125)(H,100,126)(H,101,129)(H,102,130)(H,103,127)(H,104,128)(H,105,137)(H,106,138)(H,107,139)(H,108,140)(H,109,131)(H,110,132)(H,111,133)(H,112,134)(H,113,135)(H,114,136)/t49-,50-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,77-,78-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 an... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536275
(CHEMBL4520203)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C98H150N24O26S4/c1-5-55(3)83-95(145)113-63(35-37-73(99)125)87(137)115-67(49-75(101)127)89(139)117-69(53-151-149-45-39-81(133)109-65(91(141)119-83)47-57-27-31-59(123)32-28-57)97(147)121-43-19-23-71(121)93(143)111-61(85(135)107-51-77(103)129)21-15-17-41-105-79(131)25-13-11-9-7-8-10-12-14-26-80(132)106-42-18-16-22-62(86(136)108-52-78(104)130)112-94(144)72-24-20-44-122(72)98(148)70-54-152-150-46-40-82(134)110-66(48-58-29-33-60(124)34-30-58)92(142)120-84(56(4)6-2)96(146)114-64(36-38-74(100)126)88(138)116-68(50-76(102)128)90(140)118-70/h27-34,55-56,61-72,83-84,123-124H,5-26,35-54H2,1-4H3,(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H,105,131)(H,106,132)(H,107,135)(H,108,136)(H,109,133)(H,110,134)(H,111,143)(H,112,144)(H,113,145)(H,114,146)(H,115,137)(H,116,138)(H,117,139)(H,118,140)(H,119,141)(H,120,142)/t55-,56-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,83-,84-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.00100 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GF... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536275
(CHEMBL4520203)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C98H150N24O26S4/c1-5-55(3)83-95(145)113-63(35-37-73(99)125)87(137)115-67(49-75(101)127)89(139)117-69(53-151-149-45-39-81(133)109-65(91(141)119-83)47-57-27-31-59(123)32-28-57)97(147)121-43-19-23-71(121)93(143)111-61(85(135)107-51-77(103)129)21-15-17-41-105-79(131)25-13-11-9-7-8-10-12-14-26-80(132)106-42-18-16-22-62(86(136)108-52-78(104)130)112-94(144)72-24-20-44-122(72)98(148)70-54-152-150-46-40-82(134)110-66(48-58-29-33-60(124)34-30-58)92(142)120-84(56(4)6-2)96(146)114-64(36-38-74(100)126)88(138)116-68(50-76(102)128)90(140)118-70/h27-34,55-56,61-72,83-84,123-124H,5-26,35-54H2,1-4H3,(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H,105,131)(H,106,132)(H,107,135)(H,108,136)(H,109,133)(H,110,134)(H,111,143)(H,112,144)(H,113,145)(H,114,146)(H,115,137)(H,116,138)(H,117,139)(H,118,140)(H,119,141)(H,120,142)/t55-,56-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,83-,84-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 135 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536279
(CHEMBL4567752)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C100H154N24O26S4/c1-5-57(3)85-97(147)115-65(37-39-75(101)127)89(139)117-69(51-77(103)129)91(141)119-71(55-153-151-47-41-83(135)111-67(93(143)121-85)49-59-29-33-61(125)34-30-59)99(149)123-45-21-25-73(123)95(145)113-63(87(137)109-53-79(105)131)23-17-19-43-107-81(133)27-15-13-11-9-7-8-10-12-14-16-28-82(134)108-44-20-18-24-64(88(138)110-54-80(106)132)114-96(146)74-26-22-46-124(74)100(150)72-56-154-152-48-42-84(136)112-68(50-60-31-35-62(126)36-32-60)94(144)122-86(58(4)6-2)98(148)116-66(38-40-76(102)128)90(140)118-70(52-78(104)130)92(142)120-72/h29-36,57-58,63-74,85-86,125-126H,5-28,37-56H2,1-4H3,(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H2,105,131)(H2,106,132)(H,107,133)(H,108,134)(H,109,137)(H,110,138)(H,111,135)(H,112,136)(H,113,145)(H,114,146)(H,115,147)(H,116,148)(H,117,139)(H,118,140)(H,119,141)(H,120,142)(H,121,143)(H,122,144)/t57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,85-,86-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 301 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536276
(CHEMBL4564152)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-3-23(2)36-42(66)51-27(13-14-32(45)57)38(62)52-29(20-33(46)58)39(63)53-30(22-69-68-18-15-35(60)49-28(40(64)54-36)19-24-9-11-25(56)12-10-24)43(67)55-17-6-8-31(55)41(65)50-26(7-4-5-16-44)37(61)48-21-34(47)59/h9-12,23,26-31,36,56H,3-8,13-22,44H2,1-2H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,65)(H,51,66)(H,52,62)(H,53,63)(H,54,64)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagge... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536277
(CHEMBL4541104)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C96H146N24O26S4/c1-5-53(3)81-93(143)111-61(33-35-71(97)123)85(135)113-65(47-73(99)125)87(137)115-67(51-149-147-43-37-79(131)107-63(89(139)117-81)45-55-25-29-57(121)30-26-55)95(145)119-41-17-21-69(119)91(141)109-59(83(133)105-49-75(101)127)19-13-15-39-103-77(129)23-11-9-7-8-10-12-24-78(130)104-40-16-14-20-60(84(134)106-50-76(102)128)110-92(142)70-22-18-42-120(70)96(146)68-52-150-148-44-38-80(132)108-64(46-56-27-31-58(122)32-28-56)90(140)118-82(54(4)6-2)94(144)112-62(34-36-72(98)124)86(136)114-66(48-74(100)126)88(138)116-68/h25-32,53-54,59-70,81-82,121-122H,5-24,33-52H2,1-4H3,(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H,103,129)(H,104,130)(H,105,133)(H,106,134)(H,107,131)(H,108,132)(H,109,141)(H,110,142)(H,111,143)(H,112,144)(H,113,135)(H,114,136)(H,115,137)(H,116,138)(H,117,139)(H,118,140)/t53-,54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,81-,82-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 41 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagge... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536279
(CHEMBL4567752)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C100H154N24O26S4/c1-5-57(3)85-97(147)115-65(37-39-75(101)127)89(139)117-69(51-77(103)129)91(141)119-71(55-153-151-47-41-83(135)111-67(93(143)121-85)49-59-29-33-61(125)34-30-59)99(149)123-45-21-25-73(123)95(145)113-63(87(137)109-53-79(105)131)23-17-19-43-107-81(133)27-15-13-11-9-7-8-10-12-14-16-28-82(134)108-44-20-18-24-64(88(138)110-54-80(106)132)114-96(146)74-26-22-46-124(74)100(150)72-56-154-152-48-42-84(136)112-68(50-60-31-35-62(126)36-32-60)94(144)122-86(58(4)6-2)98(148)116-66(38-40-76(102)128)90(140)118-70(52-78(104)130)92(142)120-72/h29-36,57-58,63-74,85-86,125-126H,5-28,37-56H2,1-4H3,(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H2,105,131)(H2,106,132)(H,107,133)(H,108,134)(H,109,137)(H,110,138)(H,111,135)(H,112,136)(H,113,145)(H,114,146)(H,115,147)(H,116,148)(H,117,139)(H,118,140)(H,119,141)(H,120,142)(H,121,143)(H,122,144)/t57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,85-,86-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.0110 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536278
(CHEMBL4520170)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C94H142N24O26S4/c1-5-51(3)79-91(141)109-59(31-33-69(95)121)83(133)111-63(45-71(97)123)85(135)113-65(49-147-145-41-35-77(129)105-61(87(137)115-79)43-53-23-27-55(119)28-24-53)93(143)117-39-15-19-67(117)89(139)107-57(81(131)103-47-73(99)125)17-11-13-37-101-75(127)21-9-7-8-10-22-76(128)102-38-14-12-18-58(82(132)104-48-74(100)126)108-90(140)68-20-16-40-118(68)94(144)66-50-148-146-42-36-78(130)106-62(44-54-25-29-56(120)30-26-54)88(138)116-80(52(4)6-2)92(142)110-60(32-34-70(96)122)84(134)112-64(46-72(98)124)86(136)114-66/h23-30,51-52,57-68,79-80,119-120H,5-22,31-50H2,1-4H3,(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H,101,127)(H,102,128)(H,103,131)(H,104,132)(H,105,129)(H,106,130)(H,107,139)(H,108,140)(H,109,141)(H,110,142)(H,111,133)(H,112,134)(H,113,135)(H,114,136)(H,115,137)(H,116,138)/t51-,52-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,79-,80-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536279
(CHEMBL4567752)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C100H154N24O26S4/c1-5-57(3)85-97(147)115-65(37-39-75(101)127)89(139)117-69(51-77(103)129)91(141)119-71(55-153-151-47-41-83(135)111-67(93(143)121-85)49-59-29-33-61(125)34-30-59)99(149)123-45-21-25-73(123)95(145)113-63(87(137)109-53-79(105)131)23-17-19-43-107-81(133)27-15-13-11-9-7-8-10-12-14-16-28-82(134)108-44-20-18-24-64(88(138)110-54-80(106)132)114-96(146)74-26-22-46-124(74)100(150)72-56-154-152-48-42-84(136)112-68(50-60-31-35-62(126)36-32-60)94(144)122-86(58(4)6-2)98(148)116-66(38-40-76(102)128)90(140)118-70(52-78(104)130)92(142)120-72/h29-36,57-58,63-74,85-86,125-126H,5-28,37-56H2,1-4H3,(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H2,105,131)(H2,106,132)(H,107,133)(H,108,134)(H,109,137)(H,110,138)(H,111,135)(H,112,136)(H,113,145)(H,114,146)(H,115,147)(H,116,148)(H,117,139)(H,118,140)(H,119,141)(H,120,142)(H,121,143)(H,122,144)/t57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,85-,86-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536279
(CHEMBL4567752)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C100H154N24O26S4/c1-5-57(3)85-97(147)115-65(37-39-75(101)127)89(139)117-69(51-77(103)129)91(141)119-71(55-153-151-47-41-83(135)111-67(93(143)121-85)49-59-29-33-61(125)34-30-59)99(149)123-45-21-25-73(123)95(145)113-63(87(137)109-53-79(105)131)23-17-19-43-107-81(133)27-15-13-11-9-7-8-10-12-14-16-28-82(134)108-44-20-18-24-64(88(138)110-54-80(106)132)114-96(146)74-26-22-46-124(74)100(150)72-56-154-152-48-42-84(136)112-68(50-60-31-35-62(126)36-32-60)94(144)122-86(58(4)6-2)98(148)116-66(38-40-76(102)128)90(140)118-70(52-78(104)130)92(142)120-72/h29-36,57-58,63-74,85-86,125-126H,5-28,37-56H2,1-4H3,(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H2,105,131)(H2,106,132)(H,107,133)(H,108,134)(H,109,137)(H,110,138)(H,111,135)(H,112,136)(H,113,145)(H,114,146)(H,115,147)(H,116,148)(H,117,139)(H,118,140)(H,119,141)(H,120,142)(H,121,143)(H,122,144)/t57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,85-,86-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 59 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536278
(CHEMBL4520170)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C94H142N24O26S4/c1-5-51(3)79-91(141)109-59(31-33-69(95)121)83(133)111-63(45-71(97)123)85(135)113-65(49-147-145-41-35-77(129)105-61(87(137)115-79)43-53-23-27-55(119)28-24-53)93(143)117-39-15-19-67(117)89(139)107-57(81(131)103-47-73(99)125)17-11-13-37-101-75(127)21-9-7-8-10-22-76(128)102-38-14-12-18-58(82(132)104-48-74(100)126)108-90(140)68-20-16-40-118(68)94(144)66-50-148-146-42-36-78(130)106-62(44-54-25-29-56(120)30-26-54)88(138)116-80(52(4)6-2)92(142)110-60(32-34-70(96)122)84(134)112-64(46-72(98)124)86(136)114-66/h23-30,51-52,57-68,79-80,119-120H,5-22,31-50H2,1-4H3,(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H,101,127)(H,102,128)(H,103,131)(H,104,132)(H,105,129)(H,106,130)(H,107,139)(H,108,140)(H,109,141)(H,110,142)(H,111,133)(H,112,134)(H,113,135)(H,114,136)(H,115,137)(H,116,138)/t51-,52-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,79-,80-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.00100 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Gga... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536277
(CHEMBL4541104)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C96H146N24O26S4/c1-5-53(3)81-93(143)111-61(33-35-71(97)123)85(135)113-65(47-73(99)125)87(137)115-67(51-149-147-43-37-79(131)107-63(89(139)117-81)45-55-25-29-57(121)30-26-55)95(145)119-41-17-21-69(119)91(141)109-59(83(133)105-49-75(101)127)19-13-15-39-103-77(129)23-11-9-7-8-10-12-24-78(130)104-40-16-14-20-60(84(134)106-50-76(102)128)110-92(142)70-22-18-42-120(70)96(146)68-52-150-148-44-38-80(132)108-64(46-56-27-31-58(122)32-28-56)90(140)118-82(54(4)6-2)94(144)112-62(34-36-72(98)124)86(136)114-66(48-74(100)126)88(138)116-68/h25-32,53-54,59-70,81-82,121-122H,5-24,33-52H2,1-4H3,(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H,103,129)(H,104,130)(H,105,133)(H,106,134)(H,107,131)(H,108,132)(H,109,141)(H,110,142)(H,111,143)(H,112,144)(H,113,135)(H,114,136)(H,115,137)(H,116,138)(H,117,139)(H,118,140)/t53-,54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,81-,82-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536278
(CHEMBL4520170)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C94H142N24O26S4/c1-5-51(3)79-91(141)109-59(31-33-69(95)121)83(133)111-63(45-71(97)123)85(135)113-65(49-147-145-41-35-77(129)105-61(87(137)115-79)43-53-23-27-55(119)28-24-53)93(143)117-39-15-19-67(117)89(139)107-57(81(131)103-47-73(99)125)17-11-13-37-101-75(127)21-9-7-8-10-22-76(128)102-38-14-12-18-58(82(132)104-48-74(100)126)108-90(140)68-20-16-40-118(68)94(144)66-50-148-146-42-36-78(130)106-62(44-54-25-29-56(120)30-26-54)88(138)116-80(52(4)6-2)92(142)110-60(32-34-70(96)122)84(134)112-64(46-72(98)124)86(136)114-66/h23-30,51-52,57-68,79-80,119-120H,5-22,31-50H2,1-4H3,(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H,101,127)(H,102,128)(H,103,131)(H,104,132)(H,105,129)(H,106,130)(H,107,139)(H,108,140)(H,109,141)(H,110,142)(H,111,133)(H,112,134)(H,113,135)(H,114,136)(H,115,137)(H,116,138)/t51-,52-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,79-,80-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 41 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 an... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536280
(CHEMBL4546103)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C92H138N24O26S4/c1-5-49(3)77-89(139)107-57(29-31-67(93)119)81(131)109-61(43-69(95)121)83(133)111-63(47-145-143-39-33-75(127)103-59(85(135)113-77)41-51-21-25-53(117)26-22-51)91(141)115-37-13-17-65(115)87(137)105-55(79(129)101-45-71(97)123)15-9-11-35-99-73(125)19-7-8-20-74(126)100-36-12-10-16-56(80(130)102-46-72(98)124)106-88(138)66-18-14-38-116(66)92(142)64-48-146-144-40-34-76(128)104-60(42-52-23-27-54(118)28-24-52)86(136)114-78(50(4)6-2)90(140)108-58(30-32-68(94)120)82(132)110-62(44-70(96)122)84(134)112-64/h21-28,49-50,55-66,77-78,117-118H,5-20,29-48H2,1-4H3,(H2,93,119)(H2,94,120)(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H,99,125)(H,100,126)(H,101,129)(H,102,130)(H,103,127)(H,104,128)(H,105,137)(H,106,138)(H,107,139)(H,108,140)(H,109,131)(H,110,132)(H,111,133)(H,112,134)(H,113,135)(H,114,136)/t49-,50-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,77-,78-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagge... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536276
(CHEMBL4564152)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-3-23(2)36-42(66)51-27(13-14-32(45)57)38(62)52-29(20-33(46)58)39(63)53-30(22-69-68-18-15-35(60)49-28(40(64)54-36)19-24-9-11-25(56)12-10-24)43(67)55-17-6-8-31(55)41(65)50-26(7-4-5-16-44)37(61)48-21-34(47)59/h9-12,23,26-31,36,56H,3-8,13-22,44H2,1-2H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,65)(H,51,66)(H,52,62)(H,53,63)(H,54,64)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.920 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536276
(CHEMBL4564152)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-3-23(2)36-42(66)51-27(13-14-32(45)57)38(62)52-29(20-33(46)58)39(63)53-30(22-69-68-18-15-35(60)49-28(40(64)54-36)19-24-9-11-25(56)12-10-24)43(67)55-17-6-8-31(55)41(65)50-26(7-4-5-16-44)37(61)48-21-34(47)59/h9-12,23,26-31,36,56H,3-8,13-22,44H2,1-2H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,65)(H,51,66)(H,52,62)(H,53,63)(H,54,64)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.75 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536278
(CHEMBL4520170)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C94H142N24O26S4/c1-5-51(3)79-91(141)109-59(31-33-69(95)121)83(133)111-63(45-71(97)123)85(135)113-65(49-147-145-41-35-77(129)105-61(87(137)115-79)43-53-23-27-55(119)28-24-53)93(143)117-39-15-19-67(117)89(139)107-57(81(131)103-47-73(99)125)17-11-13-37-101-75(127)21-9-7-8-10-22-76(128)102-38-14-12-18-58(82(132)104-48-74(100)126)108-90(140)68-20-16-40-118(68)94(144)66-50-148-146-42-36-78(130)106-62(44-54-25-29-56(120)30-26-54)88(138)116-80(52(4)6-2)92(142)110-60(32-34-70(96)122)84(134)112-64(46-72(98)124)86(136)114-66/h23-30,51-52,57-68,79-80,119-120H,5-22,31-50H2,1-4H3,(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H,101,127)(H,102,128)(H,103,131)(H,104,132)(H,105,129)(H,106,130)(H,107,139)(H,108,140)(H,109,141)(H,110,142)(H,111,133)(H,112,134)(H,113,135)(H,114,136)(H,115,137)(H,116,138)/t51-,52-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,79-,80-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.0120 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Gga... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536277
(CHEMBL4541104)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C96H146N24O26S4/c1-5-53(3)81-93(143)111-61(33-35-71(97)123)85(135)113-65(47-73(99)125)87(137)115-67(51-149-147-43-37-79(131)107-63(89(139)117-81)45-55-25-29-57(121)30-26-55)95(145)119-41-17-21-69(119)91(141)109-59(83(133)105-49-75(101)127)19-13-15-39-103-77(129)23-11-9-7-8-10-12-24-78(130)104-40-16-14-20-60(84(134)106-50-76(102)128)110-92(142)70-22-18-42-120(70)96(146)68-52-150-148-44-38-80(132)108-64(46-56-27-31-58(122)32-28-56)90(140)118-82(54(4)6-2)94(144)112-62(34-36-72(98)124)86(136)114-66(48-74(100)126)88(138)116-68/h25-32,53-54,59-70,81-82,121-122H,5-24,33-52H2,1-4H3,(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H,103,129)(H,104,130)(H,105,133)(H,106,134)(H,107,131)(H,108,132)(H,109,141)(H,110,142)(H,111,143)(H,112,144)(H,113,135)(H,114,136)(H,115,137)(H,116,138)(H,117,139)(H,118,140)/t53-,54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,81-,82-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggam... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536277
(CHEMBL4541104)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C96H146N24O26S4/c1-5-53(3)81-93(143)111-61(33-35-71(97)123)85(135)113-65(47-73(99)125)87(137)115-67(51-149-147-43-37-79(131)107-63(89(139)117-81)45-55-25-29-57(121)30-26-55)95(145)119-41-17-21-69(119)91(141)109-59(83(133)105-49-75(101)127)19-13-15-39-103-77(129)23-11-9-7-8-10-12-24-78(130)104-40-16-14-20-60(84(134)106-50-76(102)128)110-92(142)70-22-18-42-120(70)96(146)68-52-150-148-44-38-80(132)108-64(46-56-27-31-58(122)32-28-56)90(140)118-82(54(4)6-2)94(144)112-62(34-36-72(98)124)86(136)114-66(48-74(100)126)88(138)116-68/h25-32,53-54,59-70,81-82,121-122H,5-24,33-52H2,1-4H3,(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H,103,129)(H,104,130)(H,105,133)(H,106,134)(H,107,131)(H,108,132)(H,109,141)(H,110,142)(H,111,143)(H,112,144)(H,113,135)(H,114,136)(H,115,137)(H,116,138)(H,117,139)(H,118,140)/t53-,54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,81-,82-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.00300 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Gga... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536275
(CHEMBL4520203)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C98H150N24O26S4/c1-5-55(3)83-95(145)113-63(35-37-73(99)125)87(137)115-67(49-75(101)127)89(139)117-69(53-151-149-45-39-81(133)109-65(91(141)119-83)47-57-27-31-59(123)32-28-57)97(147)121-43-19-23-71(121)93(143)111-61(85(135)107-51-77(103)129)21-15-17-41-105-79(131)25-13-11-9-7-8-10-12-14-26-80(132)106-42-18-16-22-62(86(136)108-52-78(104)130)112-94(144)72-24-20-44-122(72)98(148)70-54-152-150-46-40-82(134)110-66(48-58-29-33-60(124)34-30-58)92(142)120-84(56(4)6-2)96(146)114-64(36-38-74(100)126)88(138)116-68(50-76(102)128)90(140)118-70/h27-34,55-56,61-72,83-84,123-124H,5-26,35-54H2,1-4H3,(H2,99,125)(H2,100,126)(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H,105,131)(H,106,132)(H,107,135)(H,108,136)(H,109,133)(H,110,134)(H,111,143)(H,112,144)(H,113,145)(H,114,146)(H,115,137)(H,116,138)(H,117,139)(H,118,140)(H,119,141)(H,120,142)/t55-,56-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,83-,84-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50205990
(CHEMBL395429 | OXYTOCIN)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE KEGG PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 pro... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536276
(CHEMBL4564152)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C43H66N12O12S2/c1-3-23(2)36-42(66)51-27(13-14-32(45)57)38(62)52-29(20-33(46)58)39(63)53-30(22-69-68-18-15-35(60)49-28(40(64)54-36)19-24-9-11-25(56)12-10-24)43(67)55-17-6-8-31(55)41(65)50-26(7-4-5-16-44)37(61)48-21-34(47)59/h9-12,23,26-31,36,56H,3-8,13-22,44H2,1-2H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,65)(H,51,66)(H,52,62)(H,53,63)(H,54,64)/t23-,26-,27-,28-,29-,30-,31-,36-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 an... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536279
(CHEMBL4567752)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C100H154N24O26S4/c1-5-57(3)85-97(147)115-65(37-39-75(101)127)89(139)117-69(51-77(103)129)91(141)119-71(55-153-151-47-41-83(135)111-67(93(143)121-85)49-59-29-33-61(125)34-30-59)99(149)123-45-21-25-73(123)95(145)113-63(87(137)109-53-79(105)131)23-17-19-43-107-81(133)27-15-13-11-9-7-8-10-12-14-16-28-82(134)108-44-20-18-24-64(88(138)110-54-80(106)132)114-96(146)74-26-22-46-124(74)100(150)72-56-154-152-48-42-84(136)112-68(50-60-31-35-62(126)36-32-60)94(144)122-86(58(4)6-2)98(148)116-66(38-40-76(102)128)90(140)118-70(52-78(104)130)92(142)120-72/h29-36,57-58,63-74,85-86,125-126H,5-28,37-56H2,1-4H3,(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H2,105,131)(H2,106,132)(H,107,133)(H,108,134)(H,109,137)(H,110,138)(H,111,135)(H,112,136)(H,113,145)(H,114,146)(H,115,147)(H,116,148)(H,117,139)(H,118,140)(H,119,141)(H,120,142)(H,121,143)(H,122,144)/t57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,85-,86-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 0.00100 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor C47A mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GF... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536278
(CHEMBL4520170)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C94H142N24O26S4/c1-5-51(3)79-91(141)109-59(31-33-69(95)121)83(133)111-63(45-71(97)123)85(135)113-65(49-147-145-41-35-77(129)105-61(87(137)115-79)43-53-23-27-55(119)28-24-53)93(143)117-39-15-19-67(117)89(139)107-57(81(131)103-47-73(99)125)17-11-13-37-101-75(127)21-9-7-8-10-22-76(128)102-38-14-12-18-58(82(132)104-48-74(100)126)108-90(140)68-20-16-40-118(68)94(144)66-50-148-146-42-36-78(130)106-62(44-54-25-29-56(120)30-26-54)88(138)116-80(52(4)6-2)92(142)110-60(32-34-70(96)122)84(134)112-64(46-72(98)124)86(136)114-66/h23-30,51-52,57-68,79-80,119-120H,5-22,31-50H2,1-4H3,(H2,95,121)(H2,96,122)(H2,97,123)(H2,98,124)(H2,99,125)(H2,100,126)(H,101,127)(H,102,128)(H,103,131)(H,104,132)(H,105,129)(H,106,130)(H,107,139)(H,108,140)(H,109,141)(H,110,142)(H,111,133)(H,112,134)(H,113,135)(H,114,136)(H,115,137)(H,116,138)/t51-,52-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,79-,80-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 117 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagge... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50536279
(CHEMBL4567752)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O)C(=O)NCC(N)=O |r| Show InChI InChI=1S/C100H154N24O26S4/c1-5-57(3)85-97(147)115-65(37-39-75(101)127)89(139)117-69(51-77(103)129)91(141)119-71(55-153-151-47-41-83(135)111-67(93(143)121-85)49-59-29-33-61(125)34-30-59)99(149)123-45-21-25-73(123)95(145)113-63(87(137)109-53-79(105)131)23-17-19-43-107-81(133)27-15-13-11-9-7-8-10-12-14-16-28-82(134)108-44-20-18-24-64(88(138)110-54-80(106)132)114-96(146)74-26-22-46-124(74)100(150)72-56-154-152-48-42-84(136)112-68(50-60-31-35-62(126)36-32-60)94(144)122-86(58(4)6-2)98(148)116-66(38-40-76(102)128)90(140)118-70(52-78(104)130)92(142)120-72/h29-36,57-58,63-74,85-86,125-126H,5-28,37-56H2,1-4H3,(H2,101,127)(H2,102,128)(H2,103,129)(H2,104,130)(H2,105,131)(H2,106,132)(H,107,133)(H,108,134)(H,109,137)(H,110,138)(H,111,135)(H,112,136)(H,113,145)(H,114,146)(H,115,147)(H,116,148)(H,117,139)(H,118,140)(H,119,141)(H,120,142)(H,121,143)(H,122,144)/t57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,85-,86-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 867 | n/a | n/a | n/a | n/a |
Institute of Neuroscience
Curated by ChEMBL
| Assay Description Agonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-... |
J Med Chem 59: 7152-66 (2016)
Article DOI: 10.1021/acs.jmedchem.6b00564 BindingDB Entry DOI: 10.7270/Q2QN6B94 |
More data for this Ligand-Target Pair | |